https://propellatx.com/wp-content/uploads/2020/04/Propella-logo-horz.svg00georgehttps://propellatx.com/wp-content/uploads/2020/04/Propella-logo-horz.svggeorge2021-01-14 15:36:052021-09-09 15:21:26Spicy Pepper Consumption and Preferences in the United States
https://propellatx.com/wp-content/uploads/2020/04/Propella-logo-horz.svg00georgehttps://propellatx.com/wp-content/uploads/2020/04/Propella-logo-horz.svggeorge2021-01-14 15:26:362021-09-09 15:21:45A Comprehensive Review of the Carcinogenic and Anticarcinogenic Potential of Capsaicin
https://propellatx.com/wp-content/uploads/2020/04/Propella-logo-horz.svg00georgehttps://propellatx.com/wp-content/uploads/2020/04/Propella-logo-horz.svggeorge2021-01-14 15:21:402021-09-09 15:21:53Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch
Propella Therapeutics Inc., a leader in the development of innovative best-in-class prescription products, today announced the issuance of a U.S. patent for a new drug treatment for metastatic prostate cancer. The patent covers new molecules that are designed to provide significant advantages over the current standard of care.
https://propellatx.com/wp-content/uploads/2020/04/Propella-logo-horz.svg00altusdevsite_4grsdfhttps://propellatx.com/wp-content/uploads/2020/04/Propella-logo-horz.svgaltusdevsite_4grsdf2021-01-14 14:56:572021-09-09 15:21:59Press Release: Propella Therapeutics Granted U.S. Patent for New Treatment for Metastatic Prostate Cancer
https://propellatx.com/wp-content/uploads/2020/04/Propella-logo-horz.svg00georgehttps://propellatx.com/wp-content/uploads/2020/04/Propella-logo-horz.svggeorge2021-01-14 01:43:342021-09-09 15:22:08Unravelling the Mystery of Capsaicin: A Tool to Understand and Treat Pain
Spicy Pepper Consumption and Preferences in the United States
Capsaicin for Osteoarthritis Pain
A Comprehensive Review of the Carcinogenic and Anticarcinogenic Potential of Capsaicin
Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch
Press Release: Propella Therapeutics Granted U.S. Patent for New Treatment for Metastatic Prostate Cancer
Propella Therapeutics Inc., a leader in the development of innovative best-in-class prescription products, today announced the issuance of a U.S. patent for a new drug treatment for metastatic prostate cancer. The patent covers new molecules that are designed to provide significant advantages over the current standard of care.
Unravelling the Mystery of Capsaicin: A Tool to Understand and Treat Pain